The Role of Extensive Lymphadenectomy in Upper Tract Malignant Disease

详细信息    查看全文

• 作者：Travis Pagliara ; Andrew Nguyen ; Badrinath Konety
• 关键词：Upper tract urothelial cancer ; Oncology ; Lymphadenectomy ; Ureteral cancer
• 刊名：Current Urology Reports
• 出版年：2014
• 出版时间：November 2014
• 年：2014
• 卷：15
• 期：11
• 全文大小：141 KB
• 参考文献：1. Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63(2):234-1. CrossRef
  2. Yates DR, Hupertan V, Colin P, Ouzzane A, Descazeaud A, Long JA, et al. Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram. Br J Cancer. 2012;106(6):1083. CrossRef
  3. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10. CrossRef
  4. Rouprêt M, Babjuk M, Compérat E, Zigeuner R, Sylvester R, Burger M, et al. European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol. 2013;63(6):1059-1. / Update of 2011 EAU Guidelines on UTUC, based on structured MEDLINE literature search citing 135 articles. CrossRef
  5. Zhang Z, Furge KA, Yang XJ, Teh BT, Hansel DE. Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladder. BMC Med Genet. 2010;3:58.
  6. Roscigno M, Cozzarini C, Bertini R, Scattoni V, Freschi M, Da Pozzo LF, et al. Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. Eur Urol. 2008;53(4):794-02. CrossRef
  7. Kondo T, Nakazawa H, Ito F, Hashimoto Y, Toma H, Tanabe K. Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract. Urology. 2007;69(2):265-. CrossRef
  8. Roscigno M, Shariat SF, Margulis V, Karakiewicz P, Remzi M, Kikuchi E, et al. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol. 2009;181(6):2482-. CrossRef
  9. Zehnder P, Desai M. Extended lymph node dissection: bladder, kidney. Curr Opin Urol. 2011;21(2):110. CrossRef
  10. Matin SF, Shariat SF, Milowsky MI, Hansel DE, Kassouf W, Koppie T, et al. Highlights from the first symposium on upper tract urothelial carcinoma. Urologic Oncology: Seminars and Original Investigations. (0). / Five highlights of the Bethesda symposium on UTUC. Of note is the emerging recognition of aristolochic acid and its role in UTUC related to Balkan endemic nephropathy and traditional Chinese herbal medicine. Other topics include gene expression, biomarkers, and new endoscopic techniques.
  11. Kondo T, Nakazawa H, Ito F, Hashimoto Y, Toma H, Tanabe K. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract. J Urol. 2007;178(4):1212-. CrossRef
  12. Kondo T, Hashimoto Y, Kobayashi H, Iizuka J, Nakazawa H, Ito F, et al. Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: impact on patient survival. Int J Urol Off J Japan Urol Assoc. 2010;17(10):848-4.
  13. Kondo T, Tanabe K. The role of lymph node dissection in the management of urothelial carcinoma of the upper urinary tract. Int J Clin Oncol. 2011;16(3):170-. / A review of state-of-the-art LND for UTUC in 2011. The authors expand on their series of UTUC patients (first published in 2007) with documented sites of primary lymph node metastasis. Their recommended template is expanded to include the interaortocaval LNs for right renal pelvis tumors and the presacral nodes for lower ureter tumors. CrossRef
  14. Meijer RP, Nunnink CJ, Wassenaar AE, Bex A, van der Poel HG, van Rhijn BW, et al. Standard lymph node dissection for bladder cancer: significant variability in the number of reported lymph nodes. J Urol. 2012;187(2):446-0. CrossRef
  15. Stein JP, Penson DF, Cai J, Miranda G, Skinner EC, Dunn MA, et al. Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol. 2007;177(3):876-1. discussion 81-. CrossRef
  16. Jarrett TW, Chan DY, Cadeddu JA, Kavoussi LR. Laparoscopic nephroureterectomy for the treatment of transitional cell carcinoma of the upper urinary tract. Urology. 2001;57(3):448-3. CrossRef
  17. Simone G, Papalia R, Guaglianone S, Ferriero M, Leonardo C, Forastiere E, et al. Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study. Eur Urol. 2009;56(3):520-. CrossRef
  18. Busby JE, Brown GA, Matin SF. Comparing lymphadenectomy during radical nephroureterectomy: open versus laparoscopic. Urology. 2008;71(3):413-. CrossRef
  19. Roscigno M, Shariat SF, Margulis V, Karakiewicz P, Remzi M, Kikuchi E, et al. The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? Eur Urol. 2009;56(3):512-. CrossRef
  20. Merseburger AS, Herrmann TRW, Shariat SF, Kyriazis I, Nagele U, Traxer O, et al. EAU guidelines on robotic and single-site surgery in urology. Eur Urol. 2013;64(2):277-1. CrossRef
  21. Ponsky LE, Cherullo EE, Sawyer M, Hartke D. Single access site laparoscopic radical nephrectomy: initial clinical experience. (Case study). J Endourol. 2008;22(4):663. CrossRef
  22. Park YH, Park SY, Kim HH. Laparoendoscopic single-site nephroureterectomy with bladder cuff excision for upper urinary tract transitional-cell carcinoma: technical details based on oncologic principles. (Clinical report). J Endourol. 2010;24(4):563. CrossRef
  23. Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology. 1998;52(4):594-01. CrossRef
  24. Brown GA, Busby JE, Wood CG, Pisters LL, Dinney CPN, Swanson DA, et al. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: time to change the treatment paradigm? BJU Int. 2006;98(6):1176-0. CrossRef
  25. Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009;115(6):1224-3. CrossRef
  26. Raman JD, Lin Y-K, Kaag M, Atkinson T, Crispen P, Wille M, et al. High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy. Urol Oncol Semin Original Inv. 2014;32(1).
  27. Seitz C, Gupta A, Shariat SF, Matsumoto K, Kassouf W, Walton TJ, et al. Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study. J Urol. 2010;184(5):1895-00. CrossRef
  28. Favaretto RL, Shariat SF, Savage C, Godoy G, Chade DC, Kaag M, et al. Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle‐invasive and non-organ confined disease in patients with upper tract urothelial carcinoma. BJU Int. 2012;109(1):77-2. CrossRef
  29. Rouprêt M, Hupertan V, Seisen T, Colin P, Xylinas E, Yates DR, et al. Prediction of cancer-specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized post-operative nomogram using decision curve analysis. J Urol. 2013.
  30. Roscigno M, Shariat SF, Freschi M, Margulis V, Karakiewizc P, Suardi N, et al. Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer. Urology. 2009;74(5):1070. CrossRef
  31. Mason RJ, Kassouf W, Bell DG, Lacombe L, Kapoor A, Jacobsen N, et al. The contemporary role of lymph node dissection during nephroureterectomy in the management of upper urinary tract urothelial carcinoma: the Canadian experience. Urology. 2012;79(4):840-. / A large North American (Canadian) multicenter retrospective study of 1,029 subjects undergoing nephroureterectomy for UTUC, comparing pN0, pN+, and pNx. Results showed significantly decreased survival for pN+ compared with pN0 and pNx subjects. Increased lymph node density was also significantly associated with decreased survival. CrossRef
  32. Lughezzani G, Jeldres C, Isbarn H, Shariat SF, Sun M, Pharand D, et al. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. Urology. 2010;75(1):118-4. CrossRef
  33. Bolenz C, Shariat SF, Fernández MI, Margulis V, Lotan Y, Karakiewicz P, et al. Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density. BJU Int. 2009;103(3):302-. CrossRef
  34. Blom JHM, van Poppel H, Maréchal JM, Jacqmin D, Schr?der FH, de Prijck L, et al. Radical nephrectomy with and without lymph node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol. 2009;55(1):28-4. CrossRef
  
• 作者单位：Travis Pagliara (1)
  Andrew Nguyen (1)
  Badrinath Konety (1)
  
  1. Department of Urology, University of Minnesota, 420 Delaware Street SE, Minneapolis, MN, USA
  
• ISSN：1534-6285

文摘

Upper tract malignancies represent an estimated 5?%-0?% of urothelial cancers, with roughly 3,000 new cases per year in the United States. These tumors often present at an advanced stage, with invasion and lymph node metastases. There are no large randomized prospective studies demonstrating the benefit of lymph node dissection in upper tract urothelial cancer, and as such, definitive guidelines on the surgical template and timing are lacking. Laparoscopic and robotic-assisted surgical techniques are well-established for nephroureterectomy, but are also emerging for retroperitoneal lymph node dissection. The treatment of these tumors still needs to be tailored based on patient and tumor characteristics. The purpose of our review is to update findings on the utility, techniques, and outcomes of lymphadenectomy for upper tract urothelial cancer.